Pulmonary Cell News Volume 14.18 | Sep 18 2025

    0
    62







    2025-09-18 | PULCN 14.18


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 14.18 – 18 September, 2025
    TOP STORY

    Phenylboronic Acid-Modified Copper Nanozymes as Nanoscavengers of Bacterial Polysaccharides Causing Acute Lung Injury

    Investigators developed 4-mercaptobenzoic acid modified copper nanozymes to simultaneously combat bacterial infections and toxin-triggered immune overactivation.
    [Advanced Science]

    Full Article
    Studying COVID-19 with ALI culture
    PUBLICATIONSListed by the impact factor of the journal

    Sorted-Cell Proteomics Reveals an AT1-Associated Epithelial Cornification Phenotype and Suggests Endothelial Redox Imbalance in Human Bronchopulmonary Dysplasia

    Researchers sorted epithelial and endothelial cell populations based on their differential surface markers from normal and bronchopulmonary dysplasia human lungs.
    [American Journal of Physiology-Lung Cellular and Molecular Physiology]

    Abstract

    Targeting ATP7A-Dependent Copper Metabolic Homeostasis Induces Cuproptosis and Suppresses the Progression of Mutant KRAS-Driven Lung Cancer

    Scientists revealed the therapeutic value of the Cu ionophore elesclomol for treating KRASG12-mutant–driven lung adenocarcinoma.
    [Cancer Research]

    Abstract

    Targeting TGF-β–Smad2/3-JNK1-Mediated SIRT1 Activity Overcomes the Chemoresistance of KRAS Mutation Lung Cancer

    The authors investigated the mechanism by which SIRT1 activity is increased and the role of pSIRT1 in the chemoresistance of KRASMut lung cancer cells.
    [Experimental & Molecular Medicine]

    Full Article

    PLK1-Mediated PDHA1 Phosphorylation Drives Metabolic Reprogramming in Lung Cancer

    Researchers demonstrated that polo-like kinase 1 (PLK1) phosphorylation of pyruvate dehydrogenase (PDH) A1 at threonine 57 drives its protein degradation via mitophagy activation.
    [Oncogene]

    AbstractGraphical Abstract

    Propofol Inhibits Lung Cancer Glycolysis by Influencing the Deubiquitination Modification of TPI1 Regulated by USP5

    The authors found that propofol impeded lung cancer progression and glycolysis. Additionally, propofol curbed the triosephosphate isomerase 1 (TPI1) protein and increased TPI1 ubiquitination modification.
    [Biochemical Genetics]

    AbstractGraphical Abstract
    Keep current with the latest in infectious disease research.
    REVIEWS

    Long Non-Coding RNAs and Signaling Networks in Non-Small Cell Lung Cancer: Mechanistic Insights into Tumor Pathogenesis

    Scientists synthesize contemporary findings on the molecular mechanisms by which lncRNAs influence major oncogenic cascades in NSCLC.
    [Cancer Gene Therapy]

    Abstract
    INDUSTRY AND POLICY NEWS

    Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas

    Helmholtz Munich and Parse Biosciences announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered by Parse Biosciences’ GigaLab platform.
    [Parse Biosciences]

    Press Release
    FEATURED EVENT

    Stem Cells & Cancer Conference

    September 28-October 1, 2025
    St. Julian’s, Malta

    > See All Events

    JOB OPPORTUNITIES

    Research Study Technician – Pulmonary Study

    Boston University – Boston, Massachusetts, United States

    Researcher – Interstitial Lung Diseases and Autoimmunity

    INSERM – Rennes, France

    Assistant/Associate/Senior Scientist – Cancer Research

    Henry Ford Health + Michigan State – Detroit, Michigan, United States

    Research Assistant – Cellular Oncoproteins in Lung and Colon Cancer

    University of Alabama at Birmingham – Birmingham, Alabama, United States

    Assistant Professor – Pulmonary Critical Care Medicine

    Fred Hutchinson Cancer Center – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2